Literature DB >> 16829756

Review of terminology of precursors of vulvar squamous cell carcinoma.

James Scurry1, Edward J Wilkinson.   

Abstract

The popular term for vulvar squamous cell carcinoma in situ/dysplasia is vulvar intraepithelial neoplasia (VIN). VIN is a histological diagnosis based on loss of squamous epithelial maturation associated with enlarged, hyperchromatic, pleomorphic nuclei and increased, usually atypical mitoses. There are two types of VIN: the usual (not otherwise specified) type, also known as warty-basaloid, and the differentiated type. There are 3 grading systems for warty-basaloid VIN: the traditional 3-grade system of VIN 1-3, a low-grade/high grade Bethesda-like system and the International Society for the Study of Vulvovaginal Disease's proposal for only 1 grade. The ISSVD system eliminates VIN 1 and combines VIN 2 and 3 on the grounds that VIN 1 has not been shown to be a reproducible diagnosis and VIN 2 and 3 are not reliably separated. The evidence supports the ISSVD proposal. Warty basaloid VIN may be sub-typed into warty and basaloid VIN. Sub-typing has clinical relevance but its reproducibility is not proven. Warty-basaloid VIN may regress. Differentiated VIN has been typically diagnosed co-incident with squamous cell carcinoma. With increased frequency of performance of biopsy of hyperplastic lesions, differentiated VIN should be diagnosed more commonly before squamous carcinoma occurs.

Entities:  

Mesh:

Year:  2006        PMID: 16829756     DOI: 10.1097/00128360-200607000-00008

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  15 in total

1.  [Involvement of mucous membranes in papulosquamous diseases].

Authors:  M Sticherling
Journal:  Hautarzt       Date:  2009-11       Impact factor: 0.751

Review 2.  [Nomenclature of squamous cell precursor lesions of the lower female genital tract : Current aspects].

Authors:  L-C Horn; C E Brambs; R Handzel; G Mehlhorn; D Schmidt; K Schierle
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

Review 3.  [HPV-associated alterations of the vulva and vagina. Morphology and molecular pathology].

Authors:  L-C Horn; K Klostermann; S Hautmann; A K Höhn; M W Beckmann; G Mehlhorn
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

4.  Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix.

Authors:  Alan G Waxman; David Chelmow; Teresa M Darragh; Herschel Lawson; Anna-Barbara Moscicki
Journal:  Obstet Gynecol       Date:  2012-12       Impact factor: 7.661

5.  [Changes in the TNM classification of gynecological tumors].

Authors:  L-C Horn; M W Beckmann; A Beller; D Schmidt; U Ulrich; P Hantschmann; C Wittekind
Journal:  Pathologe       Date:  2010-09       Impact factor: 1.011

6.  Clinical scoring system to detect malignant and premalignant vulval lesions.

Authors:  Shakun Tyagi; Reva Tripathi; Swaraj Batra
Journal:  J Obstet Gynaecol India       Date:  2013-09-01

7.  [Pathoanatomical preparation and reporting of specimens from precancerous lesions and carcinomas of the vulva].

Authors:  L-C Horn; K Schierle; K Klostermann; H-G Schnürch; P Hantschmann
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

8.  The Lower Anogenital Squamous Terminology Project and its implications for clinical care.

Authors:  Tomas Nuño; Francisco García
Journal:  Obstet Gynecol Clin North Am       Date:  2013-03-27       Impact factor: 2.844

Review 9.  Squamous precursor lesions of the vulva: current classification and diagnostic challenges.

Authors:  Lien N Hoang; Kay J Park; Robert A Soslow; Rajmohan Murali
Journal:  Pathology       Date:  2016-04-23       Impact factor: 5.306

10.  Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily.

Authors:  Giuseppina Capra; Lucia Giovannelli; Domenica Matranga; Carmelina Bellavia; Maria Francesca Guarneri; Teresa Fasciana; Giovanna Scaduto; Alberto Firenze; Alessandra Vassiliadis; Antonio Perino
Journal:  Hum Vaccin Immunother       Date:  2017-06-08       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.